partnershipHummingbird and Synaffix in $150m ADC dealLatest NewsRational antibody design specialist Hummingbird Bioscience has licenced a cancer target and the modular ADC technology of Dutch Synaffix BV. Read more 5 January 2023 https://european-biotechnology.com/wp-content/uploads/2024/04/Synaffix.png 322 608 Thomas Gabrielczyk /wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.png Thomas Gabrielczyk2023-01-05 07:25:262024-07-15 13:11:03Hummingbird and Synaffix in $150m ADC deal